Product
Placebo Dry Powder Inhaler
1 clinical trial
1 indication
Indication
AsthmaClinical trial
A 12-Week, Randomized, Placebo-Controlled, Dose-Ranging, Efficacy and Safety Study of Mometasone Furoate Metered Dose Inhaler in the Treatment of Children Ages 5 to 11 Years With Persistent Asthma (Phase 2; Protocol No. P04223AM3)Status: Completed, Estimated PCD: 2015-01-29